OpenVSafe by OpenVAERS
Search V-safe

5EC-32366-95720

5 vaccinations 11 coded responses 46 check-ins 11 free-text entries 1 call case
Sex
Male
Age at first dose
66+
ZIP prefix
018 / MA
Registered
2021-02-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-04
    Registered in v-safe
  3. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-02-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Muscular weakness — Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness
    Free text: leg weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-10
    Health check-in — day 7, dose 1
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-02-18
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-24
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-25
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event, Unevaluable event — Feeling: Good · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event, Unevaluable event — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-06
    Survey response — day 7, dose 2
    MedDRA: No adverse event — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-26
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-04-01
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-04-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-08-27
    Survey response — 6 months, dose 2
    MedDRA: Dyspnoea — Feeling: Fair
    Free text: Increased shortness of breath.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  23. 2021-09-23
    Dose 3 — Pfizer-BioNTech
  24. 2021-10-01
    Health check-in — day 7, dose 3
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  25. 2021-10-10
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  26. 2021-10-14
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  27. 2021-10-21
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  28. 2021-10-29
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  29. 2021-11-04
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  30. 2021-12-24
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  31. 2022-03-31
    Survey response — 6 months, dose 3
    MedDRA: Catheterisation cardiac abnormal, Coronary arterial stent insertion, Coronary artery occlusion, Dyspnoea, Rehabilitation therapy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cardiac. Had a cardiac cath with two stents in one partially included artery. Symptoms of shortness of breath with less and less exertion continued. Had nuclear stress test. Am now in cardiac rehab.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-03-31
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  33. 2022-04-06
  34. 2022-04-15
    Dose 4 — Pfizer-BioNTech
  35. 2022-04-15
    Health check-in — day 0, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-04-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fever · Fatigue or tiredness
    Adult check-in
  37. 2022-04-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  38. 2022-04-21
    Survey response — days 1–6 daily, dose 4
    MedDRA: Dyspnoea, Dyspnoea exertional — Feeling: Good
    Free text: Shortness of breath, primarily with exertion.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-24
    Survey response — day 7, dose 4
    MedDRA: Cardiac rehabilitation therapy, Dyspnoea exertional — Feeling: Good
    Free text: Moderate SOB with mild exertion. Am in cardiac rehab for other reasons. May or may not be related to 2nd booster.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-04-29
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-05-08
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-05-14
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-05-20
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-05-27
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-07-15
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-09-21
    Dose 5 — Pfizer-BioNTech
  47. 2022-10-04
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  48. 2022-10-05
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  49. 2022-10-13
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  50. 2022-10-19
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  51. 2022-10-26
    Survey response — day 35, dose 5
    MedDRA: Arthralgia, Muscular weakness, Nasopharyngitis — Feeling: Fair
    Free text: It feels like the beginning of a cold with aching joints and muscle weakness.
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-11-04
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  53. 2022-12-21
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  54. 2023-03-22
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Pfizer-BioNTech
22021-02-25Pfizer-BioNTech
32021-09-23Pfizer-BioNTech No
42022-04-15Pfizer-BioNTech No
52022-09-21Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-08

Systemic reaction (other): leg weakness

Release 4 — days 1–6 daily, dose 2

2021-02-27

Systemic reaction (other): No

2021-02-28

Systemic reaction (other): None

2021-03-01

Systemic reaction (other): None

2021-03-03

Systemic reaction (other): None

Release 5 — day 7, dose 2

2021-03-06

Systemic reaction (other): None

Release 9 — 6 months, dose 2

2021-08-27

Symptoms: Increased shortness of breath.

Release 11 — 6 months, dose 3

2022-03-31

Symptoms: Cardiac. Had a cardiac cath with two stents in one partially included artery. Symptoms of shortness of breath with less and less exertion continued. Had nuclear stress test. Am now in cardiac rehab.

Release 11 — days 1–6 daily, dose 4

2022-04-21

Systemic reaction (other): Shortness of breath, primarily with exertion.

Release 11 — day 7, dose 4

2022-04-24

Systemic reaction (other): Moderate SOB with mild exertion. Am in cardiac rehab for other reasons. May or may not be related to 2nd booster.

Release 12 — day 35, dose 5

2022-10-26

Symptoms: It feels like the beginning of a cold with aching joints and muscle weakness.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDCatheterisation cardiac abnormal · · ✓
SDCoronary arterial stent insertion · · ✓
SDCoronary artery occlusion · · ✓
SDDyspnoea ✓ · ✓
SDMuscular weakness · · ✓
SDNasopharyngitis · · ✓
SDRehabilitation therapy · · ✓
SROCardiac rehabilitation therapy · · ✓
SRODyspnoea · · ✓
SRODyspnoea exertional · · ✓
SROMuscular weakness ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROUnevaluable event ○ ✓ ○

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…